Patient and graft survival are similar for patients who were on hemodialysis and peritoneal dialysis prior to transplantation.
Potential donors undergoing multidetector computed tomography during their assessment should be counseled on the medical implications of incidentally discovered lesions.
Using HCV-infected kidneys greatly reduces wait time for transplantation and improves survival for patients with HCVAugust 15, 2018
1. Use of HCV-infected kidneys increased patients' quality-adjusted life expectancy. 2. Lower costs were associated with HCV-infected kidneys compared to transplanting HCV-uninfected kidneys to HCV-positive patients. Evidence Rating Level: 2 (Good) Study Rundown: Organ availability for transplantation is limited; therefore, for patients with end stage renal disease (ESRD), hemodialysis is often the final treatment compared 
All 20 recipients experienced HCV cure, good quality of life, excellent renal function.
After 2000, investigators observed a deceleration in short-term improvements in graft survival.
Recipient social support most influential factor for providers concerned with avoiding organ wastage.
Increases quality-adjusted life expectancy, reduces costs versus transplant of HCV-uninfected kidney.
From pre- to post-expansion period, 59% relative increase in Medicaid-covered preemptive listings.
Associated with increased risk of composite end point of acute rejection, allograft failure.
Increased odds of using multiple sun protection measures among organ transplant recipients.
Delaying treatment until after transplant doesn't adversely impact kidney allograft or survival.
Other concerns expressed by living donors include surgical, lifestyle, psychosocial impact of donation.
No difference in survival between recipients of organs from drug-intoxicated donors, other donors.
A study found that bladder cancer and UTUC occurred in 122.22 and 113.97 per 100,000 persons per year, respectively, among kidney transplant recipients.
Unique characteristics ID'd in peripheral blood cells of simultaneous liver-kidney transplant recipients.
1. U.S. transplants using organs from overdose-death donors (ODDs) has increased 24-fold from 2000 to 2016, and transplant outcomes from organs donated by ODDs have been noninferior to those donated by trauma-death donors (TDDs) and medical-death donors (MDDs). 2. Compared to TDD organs, ODD kidneys and livers were discarded at a greater rate. Evidence Rating 
The number of transplants in the United States involving organs from individuals who died from a drug overdose rose from 149 in 2000 to 3533 in 2016.
Nurse managers, white providers more likely to be unaware of national racial disparity in waitlisting
Kidney transplant recipients in the highest tertile of serum uromodulin concentration had a 2-fold increased risk of allograft failure compared with those in the lowest tertile.
Findings among adults undergoing kidney transplantation in Finland 1990 to 2010
Families making decision not to donate relative's organs experience lower quality communication
However, the impact in waitlisting was only seen for disadvantaged after 500 days of follow-up.
Incidence of donation stable in women but decreased among men; income tied to changes in donation
In a small study, direct-acting prophylaxis against hepatitis C virus (HCV) appeared safe and well-tolerated in uninfected recipients of HCV+ kidneys.
1. No HCV infection was detected in patients receiving HCV-infected kidneys 12 weeks following treatment. 2. No antiviral treatment-related complications occurred recipients of HCV-infected kidneys. Evidence Rating Level: 2 (Good) Study Rundown: Kidney failure and end-stage kidney disease result in significant morbidity and mortality. While kidney transplant is a viable solution for patients with kidney 
Patients with end-stage renal disease (ESRD) due to autosomal polycystic kidney disease are more likely to receive a kidney transplant than those with ESRD from other causes, new study finds.
Patients who have a failed renal allograft removed prior to undergoing another kidney transplant may be at increased risk of losing the new allograft, according to a new review.
The living kidney donor candidate evaluation process can reveal serious undiagnosed medical problems.
1. Living kidney donation was associated with higher diastolic blood pressure, lower estimated glomerular filtration rates, and increased relative risk of preeclampsia and end-stage renal disease (ESRD). 2. Data did not show that donors have a higher risk for type 2 diabetes, hypertension, cardiovascular disease, negative psychosocial health outcomes, reduced quality of life, or mortality. 
Increased risks for ESRD, preeclampsia, although absolute risk of these outcomes remains low.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)